Barinthus Biotherapeutics plc

After a month and a half initial public offering drought, two biopharmaceutical companies – Neumora Therapeutics, Inc. and RayzeBio, Inc. – launched IPOs in the US and grossed $561m combined on 14

Venture capital fundraising by biopharmaceutical firms in the second quarter was a mixed bag, according to Venture Monitor data from Pitchbook and the National Venture Capital Association (NVCA), wh

Chronically Infected HBV Patients: The Final Frontier Hepatitis B virus (HBV) is a double-stranded DNA virus that results in human infection with acute and chronic disease phases in the liver. The acu

Investment in ideas and new science takes research, and often faith to make innovation work. What may be a good idea on paper may not be scalable, or even answer an unmet need for patients. Entering t